The Only Clinically Validated Multiple Sclerosis Multi-Analyte Test Proven to Deliver Clinically Meaningful Insights Is Now Available In All 50 States MENLO PARK, Calif.--(BUSINESS WIRE)--Octave® ...
MENLO PARK, Calif.--(BUSINESS WIRE)--Octave, a leading digital health sciences company that delivers a new standard for managing multiple sclerosis (MS) and other neurodegenerative diseases, today ...
MENLO PARK, Calif., April 16, 2025--(BUSINESS WIRE)--Octave Bioscience, Inc., a leading precision care company that delivers a new standard for managing multiple sclerosis (MS) and other ...
Collaboration enables patients to access the Octave MSDA test at Quest’s approximately 7,000 patient access sites across the U.S. and establishes a pathway to introduce additional tests from Octave’s ...
Nine posters demonstrate deep insights provided by company's Multiple Sclerosis Disease Activity Test and enhanced MRI analytics and protocols Octave Bioscience, Inc., a leading precision care company ...
MENLO PARK, Calif., October 06, 2025--(BUSINESS WIRE)--Octave Bioscience, Inc., a commercial-stage precision care company pioneering biomarker-driven solutions for multiple sclerosis (MS) and other ...
Please provide your email address to receive an email when new articles are posted on . The Octave Multiple Sclerosis Disease Activity test monitors underlying disease activity in patients with MS.
MENLO PARK, Calif., September 04, 2025--(BUSINESS WIRE)--Octave Bioscience, Inc., a commercial stage precision care company that is pioneering a new standard for managing multiple sclerosis (MS) and ...
The MarketWatch News Department was not involved in the creation of this content. Collaboration enables patients to access the Octave MSDA test at Quest's approximately 7,000 patient access sites ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results